TITLE

Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar)

AUTHOR(S)
Daniel, P T; Holzschuh, J; Berg, P A
PUB. DATE
April 1989
SOURCE
Thorax;Apr1989, Vol. 44 Issue 4, p307
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66052043

 

Related Articles

  • Cytogenetic evaluation of Fansidar on human lymphocyte chromosomes in vitro. Praveen, Nuzhat; Saifi, Muheet Alam; Shadab, G. G. H. A. // Journal of Environmental Biology;Jan2011, Vol. 32 Issue 1, p95 

    Fansidar is a fixed combination of two antimalarial agents a diaminopyrimidine (Pyrimethamine) and a sulphonamide (Sulphadoxine) in the ratio 1:20- that have been used extensively worldwide for the treatment of Chloroquine resistant Plasmodium falciparum malaria, toxoplasmosis and pneumocystis...

  • Increased Carriage of Trimethoprim/Sulfamethoxazole-Resistant Streptococcus pneumoniae in Malawian Children after Treatment for Malaria with Sulfadoxine/Pyrimethamine. Feikin, Daniel R.; Dowell, Scott F.; Nwanyanwu, Okey C.; Klugman, Keith P.; Kazembe, Peter N.; Barat, Laerence M.; Graf, Cristel; Bloland, Peter B.; Ziba, Charles; Huebner, Robin E.; Schwartz, Ben // Journal of Infectious Diseases;4/1/2000, Vol. 181 Issue 4 

    Examines the increase of cotrimoxazole-resistant streptococcus pneumoniae in children treated with sulfadoxine/pyrimethamine in Dwangwa, Malawi. Use of broth microdilution in testing pneumococci antibiotic susceptibility; Etiology of pneumonia; Effective alternatives of sulfadoxine usage.

  • Randomized Trial of Weekly Sulfadoxine/Pyrimethamine vs. Daily Low-Dose Timethoprim-Sulfamethoxazole for the Prophylaxis of Pneumocystis carinii Pneumonia After Liver Transplantation. Torre-Cisneros, J.; De la Mata, M.; Pozo, J.C.; Serrano, P.; Bricentildeo, J.; Sol√≥rzano, G.; Mintildeo, G.; Pera, C.; Saacutenchez-Guijo, P. // Clinical Infectious Diseases;10/1/1999, Vol. 29 Issue 4, p771 

    Presents a study which investigated the efficacy and safety of weekly sulfadoxine/pyrimethamine compared with daily trimethoprim-sulfamethoxazole in prevention of Pneumocystis carinnii pneumonia after liver transplantation. Background on the bacteria; Characteristics of the patients; Materials...

  • Use of Pyrimethamine-Sulfadoxine (Fansidar) in Prophylaxis Against Chloroquine-Resistant Plasmodium falciparum and Pneumocystis carinii. Pearson, Richard D.; Hewlett, Erik L. // Annals of Internal Medicine;May87, Vol. 106 Issue 5, p714 

    Assesses the effectiveness of the drug pyrimethamine-sulfadoxine or fansidar in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii. Adverse effects of the drug; Indications for prophylactic use; Drugs used in the chemoprophylaxis and presumptive treatment...

  • Fansidar.  // Royal Society of Medicine: Medicines;2002, p241 

    This article presents information on Fansidar, a proprietary, prescription-only compound preparation of the antimalarial drug pyrimethamine and the sulfadoxine. It can be used to treat patients who are seriously ill with malaria, and is available as tablets. It is manufactured by Roche.

  • Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria. Hall, Anthony P.; Doberstyn, Edward B.; Karachanachetanee, Chul; Samransamruajkit, Samran; Laixuthai, Banharn; Pearlman, Eliot J.; Lampe, Richard M.; Miller, Charles F.; Phintuyothin, Pung // British Medical Journal;6/25/1977, Vol. 1 Issue 6077, p1626 

    Focuses on the sequential treatment with quinine and mefloquine and quinine and pyrimethamine-sulfadoxine for patients with falciparum malaria in Thailand. Efficacy of the treatment; Comparison between the effects of mefloquine and Fansidar; Determination of parasite concentrations in capillary...

  • Antibacterials.  // Reactions Weekly;Jul2015, Vol. 1558 Issue 1, p29 

    The article presents case report of two patients who developed drug-induced eosinophilic pneumonia (DIEP) following daptomycin treatment.

  • Sequence Variations in the Genes Encoding Dihydropteroate Synthase and Dihydrofolate Reductase and Clinical Response to Sulfadoxine-Pyrimethamine in Patients with Acute Uncomplicated Falciparum Malaria. Basco, Leonardo K.; Tahar, Rachida; Keundjian, Annick; Ringwald, Pascal // Journal of Infectious Diseases;8/1/2000, Vol. 182 Issue 2 

    Examines the efficacy of sulfadoxine-pyrimethamine of patients with acute Falcifarum malaria. Variation of gene sequence encoding with dihydropteroate synthase and dihydrofolate reductase; Clinical outcome of the treatment; Interaction of the antifolate drugs with the two enzymes of the folate...

  • Infectivity of Plasmodium falciparum gametocytes to Anopheles arabiensis after treatment with sulfadoxine-pyrimethamine. Govere, J.M.; Durrheim, D.N.; Mngomezulu, N.M.; Barnes, K.; Sharp, B. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Nov2003, Vol. 97 Issue 6, p707 

    Abstract: Sulfadoxine-pyrimethamine induces increased gametocytaemia when used for treating Plasmodium falciparum malaria. Laboratory-reared Anopheles arabiensis mosquitoes were fed with blood from patients with post-therapeutic gametocytaemia using a membrane feeder. Fourteen days later the...

  • Pulmonary toxicity of malaria prophylaxis. Davidson, A.C.; Bateman, C.; Shovlin, C.; Marrinan, M.; Burton, G.H.; Cameron, I.R. // BMJ: British Medical Journal (International Edition);11/12/88, Vol. 297 Issue 6658, p1240 

    Examines the pulmonary toxicity of malaria prophylaxis. Impact of toxicity on other body organs; Occurrence of systemic illness after pyrimethamine-sulfadoxine treatment; Importance of lung biopsy for the determination of eosinophilic pneumonia.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics